Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV): Safety and Efficacy of Broadly Neutralizing Antibodies Combined With Therapeutic Vaccination for the Induction of HIV Remission

NCT06484335 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT06484335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06484335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV): Safety and Efficacy of Broadly Neutralizing Antibodies Combined With Therapeutic Vaccination for the Induction of HIV Remission
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
March 27, 2025
Completion date
July 17, 2029
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hiv infection, art, hiv infections, plwh